Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 22, Number 8—August 2016

Middle East Respiratory Syndrome Coronavirus Transmission in Extended Family, Saudi Arabia, 2014

M. Allison Arwady, Basem M. Alraddadi, Colin Basler, Esam I. Azhar, Eltayb Abuelzein, Abdulfattah I. Sindy, Bakr M. Bin Sadiq, Abdulhakeem O. Althaqafi, Omaima Shabouni, Ayman Banjar, Lia M. Haynes, Susan I. Gerber, Daniel R. Feikin, and Tariq A. MadaniComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (M.A. Arwady, C. Basler, L.M. Haynes, S.I. Gerber, D.R. Feikin); King Faisal Specialist Hospital and Research Center, Jeddah (B. Alraddadi); Ministry of Health, Jeddah, Saudi Arabia (B. Alraddadi, E.I. Azhar, E. Abuelzein, A.I. Sindy, B.M. Bin Sadiq, A.O. Althaqafi, O. Shabouni, A. Banjar, T.A. Madani); King Abdulaziz University, Jeddah (E.I. Azhar, T.A. Madani); Ministry of National Guard, Jeddah (A.O. Althaqafi)

Main Article

Table 2

Demographic, risk factor and symptom characteristics of adults with MERS-CoV–positive and MERS-CoV–negative test results in an extended family, Al-Qouz, Saudi Arabia, 2014*

Illness at any time during preceding month
Sought medical care 13 (72) 4 (10) 6.4 (2.7–15.2)
Admitted to hospital 11 (61) 0 (0) 6.9 (3.5–13.6)
Fever 13 (72) 3 (7) 7.0 (3.0–16.5)
Cough 12 (67) 5 (23) 4.9 (2.2–11.0)
Shortness of breath 8 (44) 1 (2) 4.4 (2.4–8.1)
Diarrhea 8 (47)‡ 3 (8)§ 3.7 (1.9–7.4)
Vomiting 2 (12)‡ 1 (3)§ 2.4 (1.0–6.0)
Chills 5 (29)‡ 1 (3)§ 3.5 (1.9–6.5)
Body aches 9 (53)‡ 1 (3)§ 5.3 (2.7–10.3)

*Bold indicates statistical significance. Analysis includes all relatives 14 y of age tested for MERS-CoV (n = 59), regardless of household or visitor status. Positive indicates positive rRT-PCR or serologic antibody testing for MERS-CoV; negative indicates negative rRT-PCR and serologic antibody testing. Children (one 2-year-old rRT-PCR–positive child and 19 rRT-PCR–negative children) were excluded because they did not have serologic antibody testing. Listed chronic medical problems were self-reported; no one reported chronic lung or kidney disease, and other self-reported problems (hyperthyroidism, allergies, and solitary kidney) were excluded. MERS-CoV, Middle East respiratory syndrome coronavirus; rRT-PCR, real-time reverse transcription PCR.
†Ages were as follows: MERS-CoV positive: median 37 y (range 16–73 y); MERS-CoV-negative: median 25 y (range 14–60y).
‡Of the 17 persons for whom this information was reported.
§Of the 40 persons for whom this information was reported.

Main Article

Page created: July 15, 2016
Page updated: July 15, 2016
Page reviewed: July 15, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.